A group of independent advisers to the U.S. Food and Drug Administration (FDA) have voted to support regulatory approval of the Alzheimer’s drug Leqembi, also known by its generic name lecanemab, despite concerns surrounding three deaths during clinical trials. The six members on the Peripheral and Central Nervous System Drugs Advisory Committee on Friday all voted…
Improve Your Brain Health: Advanced Technology Offers Hope and Healing
Commentary Everybody desires health, but sadly, most Americans are not healthy enough to thrive, think with precision, feel energized, and be free of illness. The United States leads the world in medical technologies, yet life expectancy in America is the lowest of all comparable countries. At the same time, chronic disease and mental illness are…
Your Daughter for a Rat?
Commentary There are various degrees of acceptable insanity, but in general you would not want a person who thought a toad had the same intrinsic value as your mother to manage her Alzheimer’s disease. You would not want a person who equated the value of your daughter with that of a rat to decide whether…
[PREMIERE NOW] Does the Key to Curing Alzheimer’s and Rare Childhood Disease – RCDP – Lie in Plasmalogens?
March 17, 2023
admin
Alzheimer's diseaseAlzheimer’sEpochTVHealth & Safetyhealth carehealth foodLifestyleLifeStyle & LearningLive VideosPlasmalogensrcdpVideovital signs
0 Comment
Could Plasmalogen Treatment Results for RCDP* Signal Hope for Alzheimer’s Sufferers? Fifteen years of neuroscientific research led Dr Dayan Goodenowe to a landmark discovery – a single molecule much lower than normal in the blood of people with Alzheimer’s Disease. Using his own technology, he identified that molecule as plasmalogen – an essential brain nutrient…
Does the Key to Curing Alzheimer’s and Rare Childhood Disease – RCDP – Lie in Plasmalogens?
March 17, 2023
admin
Alzheimer's diseaseAlzheimer’sEpochTVHealth & Safetyhealth carehealth foodLifestyleLifeStyle & LearningLive VideosPlasmalogensrcdpVideovital signs
0 Comment
Could Plasmalogen Treatment Results for RCDP* Signal Hope for Alzheimer’s Sufferers? Fifteen years of neuroscientific research led Dr Dayan Goodenowe to a landmark discovery – a single molecule much lower than normal in the blood of people with Alzheimer’s Disease. Using his own technology, he identified that molecule as plasmalogen – an essential brain nutrient…
[PREMIERE AT 10:00AM ET] Does the Key to Curing Alzheimer’s and a Rare Childhood Disease Lie in Plasmalogens?
March 16, 2023
admin
Alzheimer’sdementiaEpochTVHealth & Safetyhealth foodLifestyleLifeStyle & LearningLive VideosrcdpVideovital signs
0 Comment
Fifteen years of neuroscientific research led Dr. Dayan Goodenowe to a landmark discovery: a single molecule much lower than normal in the blood of people with Alzheimer’s. Using his own technology, he identified that molecule as plasmalogen—an essential brain nutrient found in mothers’ breast milk. Was Alzheimer’s being caused by its depletion in brain cells?…
VHA to Cover Eisai, Biogen’s Alzheimer’s Drug for Eligible Veterans
The Veterans Health Administration (VHA) will provide coverage for Japanese company Eisai Co., Ltd and Biogen’s Alzheimer’s treatment Leqembi to eligible veterans living with early stages of Alzheimer’s disease, the companies announced on March 13. In order to be eligible for the drug, veterans will need to meet certain VHA criteria (pdf), such as having undergone an MRI scan within…
Over 80 Percent of Deaths During Pandemic Linked to COVID-19: Study
March 2, 2023
admin
Alzheimer’sAMERICACCP VirusCOVID-19 death tolldiabetesexcess deathsSARS-CoV-2 infectionsUSUS NewsVaccines & Safety
0 Comment
More than 80 percent of excess deaths in the United States between 2020 and 2022 are attributable to COVID-19, with many excess deaths from illnesses like Alzheimer’s and diabetes also tied to the infection, according to a recent study. The study looked to uncover the number of excess deaths that occurred in the country between…
Obesity Causes Alzheimer’s-Like Brain Atrophy, You May Prevent It
Obesity has long been linked to many health conditions, including cardiovascular disease, Type 2 diabetes, and some cancers. New research adds another concern: cognitive decline. The study, published in the Journal of Alzheimer’s Disease, found obesity was associated with decreased brain mass similar to that seen in Alzheimer’s disease patients. Obesity Causes Similar Changes to…
Study Finds Obese People Might Have Alzheimer’s-Like Brain Atrophy
Obesity has long been linked to many health conditions, including cardiovascular disease, Type 2 diabetes, and some cancers. New research adds another concern: cognitive decline. The study, published in the Journal of Alzheimer’s Disease, found obesity was associated with decreased brain mass similar to that seen in Alzheimer’s disease patients. Obesity Causes Similar Changes to…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta